Summary#
Bill 92, the Transparent and Accountable Health Care Act, 2023, would create a new law; it does not amend the other Acts named in it. It would bring certain health organizations and suppliers receiving at least $1 million in public funds under existing transparency and oversight laws. Its stated goal is to promote transparency and accountability in health-care funding.
- A health-sector organization receiving at least $1 million from the Ministry of Health in a qualifying fiscal year would be covered. The bill lists examples, including hospitals, long-term-care homes, and group purchasing organizations; the threshold, not the example list alone, determines coverage.
- A supplier would also be covered if it receives at least $1 million, directly or through a chain of suppliers, from those organizations. Payments for goods or services, fees, loans, and loan guarantees count. For-profit entities are included.
- Covered organizations and suppliers would be deemed employers or designated employers under two existing Acts, and governmental organizations under the Ombudsman Act, so those Acts’ requirements would apply.
- The Auditor General may audit any aspect of a covered organization’s or supplier’s operations. The bill does not require an audit.
- Some requirements start with fiscal years beginning on or after April 1, 2024. The bill says it would come into force on Royal Assent.
What it means for you#
- Health organizations and suppliers: If you meet the bill’s funding tests, you would have to comply with the requirements of the named Acts. The bill includes for-profit businesses and suppliers paid indirectly through other suppliers.
- Organizations first meeting the $1 million threshold: The executive-compensation and Ombudsman provisions would apply in the first qualifying fiscal year and every fiscal year after that. Salary-disclosure requirements and the Auditor General’s audit power apply only in fiscal years when the threshold is met.
- Public and health-care service users: The bill expands which organizations and suppliers fall under these laws, but does not itself create a new service, benefit, or public complaint process.
- Taxpayers: The bill does not change taxes or fees.
Money#
No cost information is in the available material.
- Organizations and suppliers brought under the existing Acts may have compliance costs, but the bill gives no estimate.
- The Auditor General is authorized to audit covered entities, but the bill provides no estimate of audit or staffing costs.
- The bill does not specify new funding or a spending amount.
What is unclear#
- The supplied material does not include the other Acts, so their current coverage and the exact duties that would apply cannot be verified here.
- The bill does not explain how organizations should track indirect payments through supplier chains or how disagreements about meeting the threshold would be decided.
- “Other funding arrangement” is not defined in the bill.
- The bill does not set out new application, review, appeal, reporting, or notice procedures.
- The supplied material does not say whether the bill became law. Its text says it would come into force on Royal Assent.
Case for#
- The bill appears intended to make more of the public money flowing through health care subject to existing transparency and oversight laws.
- Including suppliers and indirect payments could address cases where public funds pass through an organization before reaching a business.
- Allowing the Auditor General to audit any aspect of covered operations could help examine how public funds are used.
Case against#
- The bill does not set out how to identify covered suppliers across indirect payment chains, which could make the threshold difficult to apply consistently.
- It does not explain how expanded Ombudsman coverage would work in practice or what process an affected person could use.
- The bill allows audits of any aspect of operations but provides no details about how audit choices would be made or what resources they would require.